Molecular Characterization of the microRNA Processing Pathways

microRNA 加工途径的分子表征

基本信息

  • 批准号:
    8623138
  • 负责人:
  • 金额:
    $ 50.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-05-01 至 2016-02-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): microRNAs (miRNAs) encode ~22nt small RNAs that regulate deadenylation, translation, and decay of their target mRNAs. With the potential to regulate more that 30% of the human genes, miRNAs play fundamental roles in every aspect of biology from human development, to human disease including neuropsychiatric disorders and cancer. In animals, miRNAs are derived from characteristic hairpins processed by two sequential RNAse III enzymes, Drosha and Dicer. Our recent work has identified a novel microRNA processing pathway independent of Dicer function that depends on the catalytic activity of Argonaute2 as the initial processing step and is required for red blood cell development. Yet, the rules that govern Dicer vs. Argonaute processing and the downstream components of this pathway remain largely unknown. This proposal combines, biochemistry, mass spectrometry genetics and high-throughput sequencing with the aim to understand the structural and sequence factors that determine entry in the Argonaute vs. the Dicer processing pathway (Aim 1), identify the machinery downstream of Argonaute2 required to generate the mature miRNA through trimming and uridylation of the argonaute cleaved intermediate (Aim 2) and identify the processing requirements for all microRNAs during vertebrate development (Aim 3) using zebrafish as a model system. Abnormalities in microRNA processing have been associated with developmental defects and human cancer. In particular, miR-451 a microRNA exclusively processed by Argonaute2, is associated with glioma formation and blood disorders in humans. Thus, the identification of the machinery required downstream of Argonaute2 processing will help us understand how the dysfunction of microRNA processing might cause human birth defects and contribute to disease. In summary, the proposed experiments challenge a classical view in the field that all microRNAs are processed by Dicer have the long term goal of i) providing in-depth characterization of the processing, sequence and genomic origin of small RNAs during vertebrate development, providing an entry point to understand their function in vivo, and ii) uncovering an evolutionarily conserved machinery required to process small regulatory RNAs in vertebrates addressing fundamental questions in small RNA processing, gene regulation, RNA metabolism.
描述(由申请人提供):微小RNA(miRNA)编码~ 22 nt小RNA,其调节其靶mRNA的去腺苷化、翻译和衰变。由于有可能调节超过30%的人类基因,miRNA在从人类发育到人类疾病(包括神经精神疾病和癌症)的生物学各个方面发挥着重要作用。在动物中,miRNA来源于由两种连续的RNAse III酶Drosha和Dicer加工的特征发夹。我们最近的工作已经确定了一种新的microRNA加工途径,它独立于Dicer功能,依赖于Argonaute 2的催化活性作为初始加工步骤,并且是红细胞发育所必需的。然而,管理Dicer与Argonaute加工的规则以及该途径的下游组件在很大程度上仍然未知。 该提案结合了生物化学、质谱遗传学和高通量测序,旨在了解决定进入Argonaute与Dicer加工途径的结构和序列因素(Aim 1),通过Argonaute切割的中间体的修剪和尿苷化,鉴定Argonaute 2下游产生成熟miRNA所需的机制(Aim 2)并以斑马鱼为模型系统,确定脊椎动物发育过程中所有microRNA的加工要求(Aim 3)。 microRNA加工的异常与发育缺陷和人类癌症有关。特别是,miR-451是一种仅由Argonaute 2加工的microRNA,与人类神经胶质瘤形成和血液疾病相关。因此,Argonaute 2加工下游所需机制的鉴定将有助于我们了解microRNA加工功能障碍如何导致人类出生缺陷并导致疾病。 总之,所提出的实验挑战了本领域的经典观点,即所有microRNA都被Dicer加工,其长期目标是i)提供脊椎动物发育期间小RNA的加工、序列和基因组起源的深入表征,提供理解其体内功能的切入点,和ii)揭示脊椎动物中加工小调节RNA所需的进化上保守的机制,解决小RNA加工、基因调节、RNA代谢中的基本问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Antonio J Giraldez其他文献

Antonio J Giraldez的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Antonio J Giraldez', 18)}}的其他基金

Deciphering the regulatory code that specifies different cell fates in development using single cell genomics
使用单细胞基因组学破译指定发育过程中不同细胞命运的监管代码
  • 批准号:
    10160929
  • 财政年份:
    2020
  • 资助金额:
    $ 50.07万
  • 项目类别:
Deciphering the regulatory code that specifies different cell fates in development using single cell genomics
使用单细胞基因组学破译指定发育过程中不同细胞命运的监管代码
  • 批准号:
    10579182
  • 财政年份:
    2020
  • 资助金额:
    $ 50.07万
  • 项目类别:
Deciphering the regulatory code that specifies different cell fates in development using single cell genomics
使用单细胞基因组学破译指定发育过程中不同细胞命运的监管代码
  • 批准号:
    9974094
  • 财政年份:
    2020
  • 资助金额:
    $ 50.07万
  • 项目类别:
Deciphering the regulatory code that specifies different cell fates in development using single cell genomics
使用单细胞基因组学破译指定发育过程中不同细胞命运的监管代码
  • 批准号:
    10362629
  • 财政年份:
    2020
  • 资助金额:
    $ 50.07万
  • 项目类别:
Functional analysis of autism risk genes during neural development using single cell seq
使用单细胞测序对神经发育过程中自闭症风险基因进行功能分析
  • 批准号:
    9893904
  • 财政年份:
    2019
  • 资助金额:
    $ 50.07万
  • 项目类别:
Functional analysis of autism risk genes during neural development using single cell seq
使用单细胞测序对神经发育过程中自闭症风险基因进行功能分析
  • 批准号:
    10558696
  • 财政年份:
    2019
  • 资助金额:
    $ 50.07万
  • 项目类别:
Functional analysis of autism risk genes during neural development using single cell seq
使用单细胞测序对神经发育过程中自闭症风险基因进行功能分析
  • 批准号:
    10334483
  • 财政年份:
    2019
  • 资助金额:
    $ 50.07万
  • 项目类别:
Functional analysis of autism risk genes during neural development using single cell seq
使用单细胞测序对神经发育过程中自闭症风险基因进行功能分析
  • 批准号:
    9765793
  • 财政年份:
    2019
  • 资助金额:
    $ 50.07万
  • 项目类别:
Functional analysis of autism risk genes during neural development using single cell seq
使用单细胞测序对神经发育过程中自闭症风险基因进行功能分析
  • 批准号:
    10087965
  • 财政年份:
    2019
  • 资助金额:
    $ 50.07万
  • 项目类别:
Molecular mechanisms of the maternal to zygotic transition
母体向合子转变的分子机制
  • 批准号:
    9277085
  • 财政年份:
    2017
  • 资助金额:
    $ 50.07万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 50.07万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 50.07万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 50.07万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 50.07万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 50.07万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 50.07万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 50.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 50.07万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 50.07万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 50.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了